EDMONTON, Alberta, June 22 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) has shipped VScan HIV test kits to Germany to begin additional testing related to the CE approval of its VScan HIV test kits. While the Company has substantial testing of its VScan HIV test kit from all over the world that has shown that the VScan HIV test kit is accurate (greater than 99%), easy to use, requires no refrigeration, and does not need medical facilities we are required to conduct several tests in Europe. The initial testing will be done in Germany in regulatory approved laboratories. It is anticipated that this testing will take approximately 30 days. The Company is very confident that the VScan HIV test kit will demonstrate its usual outstanding results. Obtaining CE status will allow the Company to market its HIV test kit in an additional 26 countries. All of the necessary applications for CE status have been completed. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria, and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF." For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/. NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright